Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Innospec Inc. (IOSP:NASDAQ), powered by AI.
Innospec Inc. is currently trading at $83.74. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Innospec Inc. on Alpha Lenz.
Innospec Inc.'s P/E ratio is 17.9.
“Innospec Inc. trades at a P/E of 17.9 (fair value) with solid ROE of 9.2%.”
Ask for details →Innospec Inc. is a global specialty chemicals company that develops, manufactures, and supplies a broad range of chemical solutions to various industries. With its primary function centered around providing performance-driven products, Innospec plays a vital role in the fuel, oilfield, and personal care sectors. This company is renowned for its fuel additives, which enhance engine performance and reduce emissions, as well as for its oilfield chemicals that optimize drilling and production operations. Additionally, Innospec's personal care and fragrance offerings enrich products in the beauty and fragrance industries. In the financial markets, Innospec Inc. holds significance by addressing niche demands within the chemical space, offering innovative solutions that balance technical prowess with environmental responsibility. Its operations span across different geographic markets, creating a diversified business model that underpins its stability and growth potential. By continually investing in research and development, Innospec sustains its competitive edge and meets evolving regulatory standards, ensuring robust participation in its respective industries. Founded in 1938, Innospec is headquartered in Englewood, Colorado, and is recognized for its commitment to sustainability and advanced chemical technology.
“Innospec Inc. trades at a P/E of 17.9 (fair value) with solid ROE of 9.2%.”
Ask for details →Innospec Inc. (ticker: IOSP) is a company listed on NASDAQ in the Basic Materials sector (Specialty Chemicals). It has approximately 2,450 employees. Market cap is $2.1B.
The current price is $83.74 with a P/E ratio of 17.87x and P/B of 1.57x.
ROE is 9.19% and operating margin is 8.79%. Annual revenue is $1.8B.